Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Clinical Pain 2022; 21(2): 109-113
Published online December 31, 2022 https://doi.org/10.35827/cp.2022.21.2.109
Copyright © Korean Association of Pain Medicine.
Mi Rim Suh, M.D., Yongbum Park, M.D., Seok Hyeon Lee, M.D., Dong Yuk Lee, M.D. and Jaeki Ahn, M.D., Ph.D.
서미림ㆍ박용범ㆍ이석현ㆍ이동녘ㆍ안재기
Transforaminal cervical epidural steroid injection (TFCESI) is widely used as conservative treatment for cervical radiculopathy, but severe complications associated with this procedure have been reported. This report was the first case of intramedullary spinal cord hemorrhage following TFCESI. A 67-year-old woman presented with weakness and sensory disturbance in left upper extremity after TFCESI. Cervical magnetic resonance imaging revealed intramedullary spinal cord hemorrhage accompanied by myelopathy at the C2∼C5 level. The patient was administered intravenous methylprednisolone daily (1,000 mg/8 hours) for 5 days and was subsequently transferred to the Department of Rehabilitation Medicine for rehabilitation therapy. A month later, the patient’s neurological impairment partially improved. Although TFCESI is rarely associated with major complications, physicians should be cautious when performing the procedure, and remain mindful of the potentially serious complications.
KeywordsRadiculopathy, Injection, Spinal cord vascular diseases